Expert Review of Vaccines

Article	Citations
Indirect protection from rotavirus vaccines: a systematic review	70
Cost-effectiveness analysis of the use of PNEU-C-21 in adults aged ≥50 years in Canada	68
Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States	59
Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response	58
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic	50
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?	49
Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy	49
Vaccines against chronic Trypanosoma cruzi infection: progress, challenges and future directions	47
Response to letter to the editor on a systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	44
Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study	44
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review	43
Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in China	43
The protective effects of two varicella vaccination strategies: A Bayesian modeling study in two megacities in South China	37
Personal and contextual determinants of COVID-19 vaccination intention: a vignette study	36
Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection	36
Addressing barriers to and strategies for herpes zoster vaccination in immunocompromised patients in Türkiye: an expert consensus	36
Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis	35
Epidemiological shifts in coxsackievirus A-induced hand, foot, and mouth disease in China, 2008–2024	34
The important lessons lurking in the history of meningococcal epidemiology	33
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era	31
Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays	30
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis	28
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom	28
Microarray patches: scratching the surface of vaccine delivery	27
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany	27

Off-Label use of vaccines may save lives and money: lessons from the province of Quebec, Canada	26
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy	26
Addressing RSV infection in older adults: implications for public health policy	26
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above	26
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis	25
Vaccine hesitancy among 0–6-year-olds’ guardians in Chongqing: a cross-sectional survey revealing how immunization program managers’ robust comprehensive capacity for adverse events following immuniza	25
Birth order and influenza vaccination: a comparative study of behaviors and intentions between first-time and second-time Chinese parents	24
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond	24
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment	23
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative	23
Two decades of GSK rotavirus vaccine (RV1): a global analysis to estimate vaccination completion and deaths averted in children under 5 years	23
Vaccines preventing neonatal sepsis: focus on Group B Streptococcus , Klebsiella pneumoniae and	22
Impact of acellular immunization against pertussis; comparative experience of four countries in North, Central and South America	22
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States	22
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion	22
COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021	21
TAK-003: development of a tetravalent dengue vaccine	21
Modeling the potential public health and economic impact of COVID-19 vaccination strategies using an adapted vaccine in Peru	21
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis	21
Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany	21
Travelers’ preferences for tick-borne encephalitis vaccination	21
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan	21
Cost-effectiveness of cell-based influenza vaccine in France	21
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China	20
Regional molecular epidemiology of dengue and the potential optimization of its control through the use of vaccines. Report of the Arbovirus Committee of the Latin American Society of Pediatric Infect	20
Reply to: Letter to Editor “Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine”	20
Potential public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in India and Southeast Asia	20
Genetic predisposition to adverse events in Chinese children aged 3-24 months after diphtheria, tetanus, acellular pertussis and haemophilus influenzae type b combined vaccination	20
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China	19
Adjuvant system AS01: from mode of action to effective vaccines	19
The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems	19
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population	19
Vaccines against mpox: MVA-BN and LC16m8	19
Anti-neuraminidase immunity in the combat against influenza	18
Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine	18
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months o	18
Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children	18
Vaccination policies for dentists and other dental professionals in Europe: a systematic report	18
Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination	18
The impact of a pneumococcal vaccination on disease activity in children and adolescents with inflammatory bowel disease: a 2-year prospective study	17
Impact of rotavirus vaccination on diarrheal disease burden of children in South America	17
The durability of vaccine-induced protection: an overview	17
Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease	17
Innovation and immunization program management: traceability and quality in Latin America and the Caribbean, laying the groundwork for a regional action plan	17
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan	17
Suspended cell lines for inactivated virus vaccine production	17
A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines	17
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study	17
Changes in serotype distribution and antimicrobial nonsusceptibility of Streptococcus pneumoniae among hospitalized children: Shenzhen, China, 2009–2019	17
Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review	16

Preventing COVID-19 in at-risk populations: moving toward next-generation mRNA-1283 COVID-19 vaccine to address current challenges	16
Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States	16
Toward an effective Staphylococcus vaccine: why have candidates failed and what is the next step?	16
Pneumococcal conjugate vaccines in older adults and immunocompromised individuals	15
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review	15
Public health impact and return on investment of the pediatric immunization program in Poland	15
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks	15
Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs	15
A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome	15
Estimating the time required to reach HPV vaccination targets across Europe	15
Making COVID-19 mRNA vaccines accessible: challenges resolved	14
Cost-effectiveness of maternal vaccination against respiratory syncytial virus in Hong Kong: a decision-analytical analysis	14
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses	14
Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine	14
Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study	14
Next generation live-attenuated influenza vaccine platforms	14
Expert review on global real-world vaccine effectiveness against SARS-CoV-2	14
Health behaviors are largely not predictive of adverse events following influenza vaccination	13
Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain	13
Exploring determinants of vaccine hesitancy among healthcare professionals: a systematic literature review	13
Correction	13
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage	13
Rebuilding vaccine confidence in Latin America and the Caribbean: strategies for the post-pandemic era	13
Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study	13
Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice	13
Vaccines against SARS-CoV-2 variants and future pandemics	13
Have mRNA vaccines sentenced DNA vaccines to death?	13
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza	13
COVID-19 and vaccination: myths vs science	13
Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution	12
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines	12
Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions	12
Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis	12
PPSV-23 recommendation and vaccination coverage in China: a cross-sectional survey among healthcare workers, older adults and chronic disease patients	12
Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older	12
Vaccination strategies for solid organ transplant candidates and recipients: insights and recommendations	12
Emergence of mRNA vaccines in the management of cancer	12
Reverse engineering approach: a step towards a new era of vaccinology with special reference to Salmonella	12
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants	11
Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data	11
Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan	11
Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches	11
Correction	11
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis	11
Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives	11
Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons	11
Subolesin: a 20-year path from discovery to an effective tick vaccine	11
Evaluation of varicella outbreak control following implementation of a two-dose free vaccination policy in Wuxi, China (2014–2024)	10
An overview: CRISPR/Cas-based gene editing for viral vaccine development	10
Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018–2024: a database study	10
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context	10
A human Lyme disease vaccine: two steps forward on the path to prevention	10
Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand	10
Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	10
Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​”	10
A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson’s disease	10
Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen	9
Strengths and limitations of non-survey-based data sources for assessing adult vaccination coverage in the United States	9
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia	9
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes	9
Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions	9
COVID-19 vaccine design and vaccination strategy for emerging variants	9
Research progress on immune mechanism and control strategy of dsRNA impurities in mRNA vaccine	9
Application of reverse cumulative distribution curve and scaled logit model in determining optimal immunogenic dose and prediction of protection of EV71 vaccines	9
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore	9
Pneumococcal vaccination willingness and influencing factors among older adults in Chongqing, China: a cross-sectional study based on the WHO’s behavioral and social drivers of vaccination framework	9
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies	9
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in Italy	9
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan	8
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies	8
Public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in six Latin American countries	8
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses	8
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis	8
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant	8
Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity	8
Herpes zoster vaccine awareness and determinants among chinese adults aged ≥ 60 years: a cross-sectional study	8
Effectiveness of CoronaVac primary series with and without booster against hospitalized COVID-19 during the Omicron-predominant epidemic wave in the Philippines: a test-negative case–control study	8
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 schedule	8
Cost-effectiveness of nonavalent HPV vaccination in the Netherlands	8
Adult vaccination against respiratory infections in Egypt: a review of expert opinions	8

The role of bactericidal and opsonic activity in immunity against Bordetella pertussis	8
A review of data systems for assessing the impact of HPV vaccination in selected high-income countries	8
Measuring psychosocial determinants of vaccination behavior in healthcare professionals: validation of the Pro-VC-Be short-form questionnaire	8
Healthcare providers’ preferences for pediatric pneumococcal vaccination recommendations in the United States	8
Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data	8
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness	8
Cross-neutralization effect of the third dose of inactivated COVID-19 vaccine against the SARS-CoV-2 variants	7
Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial	7
The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis	7
No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation	7
Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study	7
Tackling vaccine inequity in 2023: have we made progress?	7
Antigenic drift in SARS-CoV-2: diminished vaccine protection in pediatric populations against Omicron and its JN.1 subvariant	7
A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in China	7
Risk of herpes zoster following mRNA COVID-19 vaccine administration	7
Respiratory syncytial virus infection and the need for immunization in Korea	7
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy	7
Impact of prior COVID-19 vaccination on major adverse kidney events in patients with non-dialysis dependent chronic kidney disease: a global retrospective study	7
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis	7
Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs	7
Vaccination against pertussis in Latin American preterm and low-birth weight infants: experts opinion position for a neglected childhood age group	6
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020	6
The quest for an HIV-1 vaccine: will mRNA deliver us from evil?	6
Interrupted time-series analysis of nationwide surveillance in Thai adult pneumococcal diseases over 14 years: evidence to inform policy in resource-limited countries	6
The broader benefits of vaccines: methodologies for inclusion in economic evaluation	6
The use of electroporation to deliver DNA-based vaccines	6
Combatting infectious diarrhea: innovations in treatment and vaccination strategies	6
Beyond aggregate estimates: stratified self-controlled case series analyses and insights into COVID-19 vaccine safety	6
Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review	6
Global variations in immunisation strategies against pertussis in infancy	6
The zebrafish as a potential model for vaccine and adjuvant development	6
Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate	6
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India	6
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers	6
Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults	6
Adult vaccination in three Eastern Mediterranean countries: current status, challenges and the way forward	6
Novel approaches to reactivate pertussis immunity	5
Control measures for neglected tropical diseases: vaccine updates	5
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies	5
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia	5
Contextual adaptation and validation of the international Pro-VC-Be tool for measuring healthcare worker vaccine confidence in Nigeria	5
Broad-spectrum coronavirus vaccines: integrated strategies to combat viral diversity	5
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews	5
The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and met	5
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England	5
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children	5
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis	5
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study	5
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?	5
Immunization information systems’ implementation and characteristics across the world: a systematic review of the literature	5
Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights	5
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities	5
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong	5
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines	5
Incidence of stroke following COVID-19 vaccination: a nationwide self‑controlled risk interval study in Qatar	5
COVID-19 vaccines: the start of a new era in regulation?	5
An analysis of causality assessed serious and severe adverse events following COVID-19 vaccines administered from January 2021 to September 2022 in India	5
Eliminating nonmedical exemptions: a radical shift in how childhood vaccine mandates govern	5